MedTrace Logo

Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.

NCT03394768 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2021-05-11

Study results available
· View outcomes & findings →

Summary

Cardiac output (CO) monitoring is an important tool in critically ill patients with haemodynamic instability. Traditionally, this has been accomplished using the pulmonary artery catheter (PAC). However, its use has been associated with various complications such as pneumothorax, arrhythmia, infection, pulmonary valve injury and embolism. This has led to the development of various minimally invasive cardiac output monitoring devices such as the oesophageal Doppler, PiCCO®, NiCCO® and FloTrac®. These devices however have their inherent limitations and though minimally invasive, are still not without risks to the patient. More recently a completely non-invasive CO monitoring device, NICOM Cheetah® has been introduced. Its use is based on thoracic bioreactance and it involves placement of 4 electrodes on either side of the thorax and it analyses changes in the phase of electrical voltage signal to the current applied across the thorax. Initial validation studies on the NICOM Cheetah® device revealed promising results. This study intends to compare cardiac output monitoring capabilities of the NICOM Cheetah® device using the FloTrac® CO monitor as a reference.

Conditions

  • Cardiac Output, Low

Interventions

OTHER

No additional intervention

Patients will be treated as per department protocols and no additional intervention will be performed

Sponsors & Collaborators

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • See Seong Chang, MBBS, MMed · Changi General Hospital

  • Louis Ng, MBBS, ANZCA · Changi General Hospital

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2021-01-05
Completion
2021-01-05

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394768 on ClinicalTrials.gov